The Public Health Systems Research Institute (PHRI) and Novo Nordisk Pharma (Thailand) Co. have signed a major...
South Korea-based Samsung Bioepis Co. has entered into a license, development and commercialisation agreement with Nipro...
US-based Foldax® Inc., a leader in heart valve innovation, has announced that the Indian Central Drugs Standard Cont...
MarkHerz Inc., a South Korea-based biotechnology startup specialising in AAV-based gene therapies targeting cardiovascul...
Eisai Co. has announced the launch of Pariet® S”(pharmaceutical requiring guidance), which is highly effective...
What are the major plans in store at HOYA Vision Care for 2025, for the Asia market? Asia remains a key market for HOYA...
The biopharma job market has been tough, with widespread downsizing and frequent layoffs across big pharma. But the wors...
Biotech partnerships of APAC differ in a variety of ways from most global collaborations, primarily due to the unique ge...
Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has announced the Australian registration of SKY...
Nuclera, a UK-based biotechnology company accelerating protein expression and optimisation through its benchtop eProtein...
Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, has announced the est...
Australia-based IonOpticks, developer of chromatography columns for mass spectrometry research, has announced the l...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Adalvo Limited in the Europe...
ICPI Week 2025 Wrap-Up ICPI WEEK 2025 WRAP-UP | BY MANBEENA CHAWLA, EXECUTIVE EDITOR, BIOSPECTRUM ASIA ...
Eli Lilly and Company has announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing aut...
Ireland-headquartered Medtronic plc, a global leader in healthcare technology, has announced its intent to separate its ...
Australia-based Kailo Medical, a global leader in structured reporting for medical imaging, has announced its acquisitio...
Pfizer Inc. has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc., a leading Chinese biop...
